|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 19/00 | (2006.01) |
| A61K 38/00 | (2013.01) | ||
| C07K 14/605 | (2006.01) | ||
| A61K 47/549 | (2017.08) | ||
| A61K 38/26 | (2006.01) | ||
| A61K 38/26 | (2013.01) | ||
| C07K 14/605 | (2013.01) | ||
| A61K 47/50 | (2017.01) | ||
| A61P 31/10 | (2006.01) | ||
| A61P 3/04 | (2018.01) | ||
| A61P 31/10 | (2018.01) | ||
| A61P 3/08 | (2018.01) | ||
| A61P 9/00 | (2018.01) | ||
| A61P 9/10 | (2018.01) | ||
| A61P 9/12 | (2018.01) | ||
| A61P 3/10 | (2018.01) | ||
| Y02P 20/55 | (2015.11) |
| (11) | Number of the document | 3155017 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15798956.7 |
| Date of filing the European patent application | 2015-05-28 | |
| (97) | Date of publication of the European application | 2017-04-19 |
| (45) | Date of publication and mention of the grant of the patent | 2024-01-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/033042 |
| Date | 2015-05-28 |
| (87) | Number | WO 2015/184177 |
| Date | 2015-12-03 |
| (30) | Number | Date | Country code |
| 201462004156 P | 2014-05-28 | US |
| (72) |
NESTOR, John, J. , US
|
| (73) |
Mederis Diabetes, LLC ,
7515 Guinevere Drive, Sugar Land, Texas 77479,
US
|
| (54) | IMPROVED PEPTIDE PHARMACEUTICALS FOR INSULIN RESISTANCE |
| IMPROVED PEPTIDE PHARMACEUTICALS FOR INSULIN RESISTANCE |